Email Us Here

FDA's New Attitude About Drug Safety Questioned

The recent release of numbers on the FDA's performance over the past year does little to support the FDA's announced new attitude about drug safety. The FDA is in need of major changes in the premarket testing and postmarket monitoring of drugs.